The influence of chronic renal failure on the spectrum and antimicrobial susceptibility of uropathogens in community-acquired acute pyelonephritis presenting as a positive urine culture

BMC Infectious Diseases

Hark Rim¹  Ho Sik Shin¹  Yeon Soon Jung¹ 

[1] Department of Internal Medicine, Kosin University College of Medicine, Busan, Republic of Korea

关键词: Antimicrobial Susceptibility;    Chronic Renal Failure;    Pyelonephritis;   

Others  :  1175747
DOI  :  10.1186/1471-2334-11-102

 received in 2010-12-27, accepted in 2011-04-21,  发布年份 2011

【 摘 要 】

Background

The role of chronic renal failure (CRF) in the antimicrobial resistance of uropathogens in patients with community-acquired acute pyelonephritis (APN) remains poorly understood.

Method

We performed a retrospective analysis of 502 adults (54 men, 448 women; mean age 61.7 ± 16.0 years, range 18-98 years) who were treated for community-acquired APN at Kosin University Gospel Hospital (Busan, Republic of Korea) during a ten-year period (January 2000 to December 2009). We evaluated the spectra and antimicrobial susceptibility profiles of uropathogens in CRF and non-CRF patients with community-acquired APN that presented as a positive urine culture.

Results

The 502 adult subjects were classified as either non-CRF APN patients (336 patients, 66.9%) or CRF APN patients (166 patients, 33.1%) according to their estimated glomerular filtration rate. No significant differences in the sensitivity of E. coli to a third cephalosporin, aminoglycoside (except gentamycin), or ciprofloxacin were observed between non-CRF and CRF patients.

Conclusions

In our series of patients with community-acquired APN that initially presented as a positive urine culture, CRF did not influence the isolation rates of different uropathogens or their patterns of susceptibility to antimicrobials.

【 授权许可】

   
2011 Jung et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Stamm WE, Hooton TM: Management of urinary tract infections in adults. N Engl J Med 1993, 329:1328-34.
• [2]Hooton TM, Stamm WE: Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997, 11:551-81.
• [3]Gupta K, Hooton TM, Wobbe CL, Stamm WE: The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents 1999, 11:305-8.
• [4]Scholes D, Hooton TM, Roberts PL, Gupta K, Stapleton AE, Stamm WE: Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005, 142:20-7.
• [5]Bonadio M, Costarelli S, Morelli G, Tartaglia T: The influence of diabetes mellitus on the spectrum of uropathogens and the antimicrobial resistance in elderly adult patients with urinary tract infection. BMC Infect Dis 2006, 6:54. BioMed Central Full Text
• [6]Descamps-Latscha B, Chatenoud L: T cells and b cells in chronic renal failure. Semin Nephrol 1996, 16:183-91.
• [7]Bergman SJ, Speil C, Short M, Koirala J: Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations. Infect Dis Clin North Am 2007, 21:821-46.
• [8]Safrin S, Siegel D, Black D: Pyelonephritis in adult women: Inpatient versus outpatient therapy. Am J Med 1988, 85:793-8.
• [9]Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16:128-40.
• [10]Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabetes Care 2003, 26(1):S5-20.
• [11]Stevens LA, Coresh J, Greene T, Levey AS: Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006, 354:2473-83.
• [12]Johnson CA, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G: Clinical practice guidelines for chronic kidney disease in adults: Part i. Definition, disease stages, evaluation, treatment, and risk factors. Am Fam Physician 2004, 70:869-76.
• [13]Jorgensen JH, Hindler JF: New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis 2007, 44:280-6.
• [14]Livermore DM: Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995, 8:557-84.
• [15]Nicolle LE: Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 2008, 35:1-12.
• [16]Bonadio M, Meini M, Spitaleri P, Gigli C: Current microbiological and clinical aspects of urinary tract infections. Eur Urol 2001, 40:439-44. discussion 445
• [17]Stapleton A: Urinary tract infections in patients with diabetes. Am J Med 2002, 113(1):80S-4S.
• [18]Bean DC, Krahe D, Wareham DW: Antimicrobial resistance in community and nosocomial escherichia coli urinary tract isolates, london 2005-2006. Ann Clin Microbiol Antimicrob 2008, 7:13. BioMed Central Full Text
• [19]Gupta K, Hooton TM, Stamm WE: Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001, 135:41-50.
• [20]van der Starre WE, van Nieuwkoop C, Paltansing S, Van't JW, Groeneveld GH, Becker MJ, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Leyten EM, Blom JW, van Dissel JT: Risk factors for fluoroquinolone-resistant escherichia coli in adults with community-onset febrile urinary tract infection. J Antimicrob Chemother 2010, 1-7.
• [21]Tonelli M, Wiebe N, Culleton B, House A, Rabbat C, Fok M, McAlister F, Garg AX: Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006, 17:2034-47.
• [22]Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP: Opportunities for improving the care of patients with chronic renal insufficiency: Current practice patterns. J Am Soc Nephrol 2001, 12:1713-20.
• [23]Fried LF, Katz R, Sarnak MJ, Shlipak MG, Chaves PH, Jenny NS, Stehman-Breen C, Gillen D, Bleyer AJ, Hirsch C, Siscovick D, Newman AB: Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol 2005, 16:3728-35.